Has Jubin Joseph, MD received payments from drug or device companies?

Yes. Drug and device makers reported $216,867 in general payments to Jubin Joseph, MD across 680 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jubin Joseph, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jubin Joseph, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jubin Joseph, MD

Interventional Cardiology · Los Angeles, CANPI 1497341747

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Edwards Lifesciences at 44.0% of the total. 2025 is the largest year on record at $106,265, more than ten times the $468 reported in 2021. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$216,867in general payments, 2019–2025

Across 680 payments — averaging $318.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$96K
Boston Scientific$47K
Abiomed$28K
Jenavalve Technology, Inc.$20K
Abbott$17K
Ancora Heart, Inc.$5K
plus $6K from 10 others

$94,661in research payments, 2019–2025

Across 7 payments — averaging $13,523 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$76K
Boston Scientific$18K

What the payments were for

Consulting fees$99,06646%
Speaking & faculty fees$57,77527%
Grants$1250%
Travel & lodging$26,43412%
Food & beverage$33,45115%
Entertainment$170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	341	$95,517
Boston Scientific	75	$46,580
Abiomed	107	$27,626
Jenavalve Technology, Inc.	4	$19,748
Abbott	85	$17,108
Ancora Heart, Inc.	13	$4,601
Medtronic	33	$3,695
Philips North America LLC	2	$844
Shockwave Medical, Inc	5	$588
Asahi Intecc USA, Inc.	1	$142
W. L. Gore & Associates, Inc.	8	$136
Amgen	1	$119
Heartflow, Inc.	2	$89
Regeneron Healthcare Solutions, Inc.	1	$40
Opsens Inc.	1	$17
Cook Medical LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$52,538
GENERAL VASCULAR ACCESS$29,375
Impella$22,124
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$20,479
JenaValve Pericardial TAVR System$19,748
MitraClip$14,101
SAPIEN 3 Ultra RESILIA$6,942
AccuCinch$4,236
COREVALVE EVOLUT R$1,545
APOLLOTM$1,147
AVVIGO Guidance System$1,095
IGT Devices Und$844
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$577
EVOQUE$375
PASCAL$323
Emerge Push$288
General - Balloon Catheters$171
WATCHMAN FLX$169
GENERAL ATHERECTOMY$168
LUX-Dx Insertable Cardiac Monitor$163

How this compares

$216,867 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024

$184,068

Medicare patients

768

Services billed

1,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	21	$16,870
EliquisApixaban	13	$10,119
Repatha SureclickEvolocumab	12	$6,604
BrilintaTicagrelor	11	$4,881
Atorvastatin Calcium	54	$642
Felodipine ErFelodipine	13	$469
ClopidogrelClopidogrel Bisulfate	33	$388
Amlodipine Besylate	67	$345
Metoprolol Succinate	25	$319
Furosemide	31	$184
Enalapril Maleate	12	$176
Metoprolol Tartrate	19	$172
Losartan Potassium	12	$167
Rosuvastatin Calcium	12	$136
Isosorbide Mononitrate ErIsosorbide Mononitrate	17	$133

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Los Angeles

Evan ZahnLos Angeles$632K
Steven BursteinLos Angeles$352K
Ali NsairLos Angeles$162K
Ray MatthewsLos Angeles$159K
Daniel AsemotaLos Angeles$155K
Christina EconomidesLos Angeles$150K
Aakriti GuptaLos Angeles$139K
Matthew Pricela Jolla$2.3M
Frederick St GoarMountain View$2.2M
Saibal KarThousand Oaks$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →